Literature DB >> 9264009

Insulin resistance in adult polycystic kidney disease.

K Vareesangthip1, P Tong, R Wilkinson, T H Thomas.   

Abstract

Adult polycystic kidney disease (APKD) is a common hereditary disease with renal and extra-renal manifestations. There are at least three genes responsible for this disease. The polycystic kidney disease 1 (PKD1) gene product is a membrane protein involved in cell-cell and cell-matrix interactions and has a widespread tissue distribution. Abnormal membrane fluidity in erythrocytes from APKD patients is due to altered membrane proteins. Membrane fluidity of mononuclear cells is related to whole body insulin sensitivity. Insulin sensitivity might therefore be disturbed in APKD if the erythrocyte membrane abnormality is also present in other cells. Therefore, we investigated insulin sensitivity in 15 APKD patients and 20 normal subjects matched for age and sex. Insulin sensitivity was assessed by a short insulin tolerance test to derive the first-order rate constant for the disappearance of glucose (Kitt) and mononuclear leukocyte membrane fluidity was measured by fluorescence anisotropy. The Kitt value (% mmol.liter-1.min-1) was lower in APKD patients than in normal subjects [median (range) 2.2 (1.5 to 6.3) vs. 4.1 (2.0 to 5.4). P < 0.001]. Fasting plasma insulin concentrations were negatively correlated with the Kitt values (r = -0.66, P < 0.001). Core region anisotropy was significantly lower (higher fluidity) in leukocytes from APKD patients [mean (SEM) 0.164 (0.003) vs. 0.174 (0.001), P < 0.001]. Insulin sensitivity was positively correlated with the fluorescence anisotropy of the core region of leukocyte membranes (r = 0.81, P = 0.0001). In conclusion, APKD patients were insulin resistant and some patients were hyperinsulinemic, which may indicate increased cardiovascular risk. The cellular basis of the insulin resistance may be directly related to the proteins causing the disease or to the general change in membrane properties.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9264009     DOI: 10.1038/ki.1997.360

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Association of metabolic syndrome with development of new-onset diabetes after transplantation.

Authors:  Nathaniel D Bayer; Philip T Cochetti; Mysore S Anil Kumar; Valerie Teal; Yonghong Huan; Cataldo Doria; Roy D Bloom; Sylvia E Rosas
Journal:  Transplantation       Date:  2010-10-27       Impact factor: 4.939

2.  The relation of anthropometric measurements and insulin resistance in patients with polycystic kidney disease.

Authors:  Bennur Esen; Emel Sağlam Gokmen; Mahmut Kaya; Burak Ozkan; Ahmet Engin Atay
Journal:  J Transl Int Med       Date:  2016-09-23

Review 3.  Post-transplant diabetes mellitus: risk reduction strategies in the elderly.

Authors:  Alain Duclos; Lawrence M Flechner; Charles Faiman; Stuart M Flechner
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  A prospective controlled study of living kidney donors: three-year follow-up.

Authors:  Bertram L Kasiske; Teresa Anderson-Haag; Ajay K Israni; Roberto S Kalil; Paul L Kimmel; Edward S Kraus; Rajiv Kumar; Andrew A Posselt; Todd E Pesavento; Hamid Rabb; Michael W Steffes; Jon J Snyder; Matthew R Weir
Journal:  Am J Kidney Dis       Date:  2015-03-17       Impact factor: 8.860

5.  Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease.

Authors:  Vandana Menon; Darya Rudym; Priya Chandra; Dana Miskulin; Ronald Perrone; Mark Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-09       Impact factor: 8.237

Review 6.  Is autosomal dominant polycystic kidney disease an early sweet disease?

Authors:  Angélique Dachy; Jean-Paul Decuypere; Rudi Vennekens; François Jouret; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2022-01-05       Impact factor: 3.651

7.  A prospective controlled study of kidney donors: baseline and 6-month follow-up.

Authors:  Bertram L Kasiske; Teresa Anderson-Haag; Hassan N Ibrahim; Todd E Pesavento; Matthew R Weir; Joseph M Nogueira; Fernando G Cosio; Edward S Kraus; Hamid H Rabb; Roberto S Kalil; Andrew A Posselt; Paul L Kimmel; Michael W Steffes
Journal:  Am J Kidney Dis       Date:  2013-03-22       Impact factor: 8.860

Review 8.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

9.  Abnormal glyceraldehyde-3-phosphate dehydrogenase binding and glycolytic flux in Autosomal Dominant Polycystic Kidney Disease after a mild oxidative stress.

Authors:  C Dioudis; G Dimitrios; T H Thomas; I C West
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

10.  Insufficient renal 1-alpha hydroxylase and bone homeostasis in aged rats with insulin resistance or type 2 diabetes mellitus.

Authors:  Huang Chang-Quan; Dong Bi-Rong; He Ping; Lu Zhen-Chan
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.